idecabtagene vicleucel
Bms,2Seventy Bio
['equate', 'ide-cel', 'myeloid', 'mds']
characterization of cytopenia following anti-bcma car-t: study from - 1/3 of pts of patients had g 3-4 cytopenia 4 months after car-t, 30% with cytopenia - older age, prior tx and hx of astct are risk factors
- higher mds incidence
#ash22 
Hem/Onc fellow @WeillCornell | #bmtsm #Celltherapy I share my tweets in @HematologyTweet